Stock BDRX BIODEXA PHARMACEUTICALS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Biodexa Pharmaceuticals Plc

Equities

BDRX

US59564R7089

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-09 pm EDT 		5-day change 1st Jan Change
0.8207 USD -5.54% Intraday chart for Biodexa Pharmaceuticals Plc -8.50% -69.38%
Jul. 03 European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading MT
Jul. 02 Biodexa Pharmaceuticals PLC Announces Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024 CI

Evolution of the average Target Price on Biodexa Pharmaceuticals Plc

Price target over the last 5 years

History of analyst recommendation changes

e65af0a761f8c548b4277dd0d7.mSp_Qc2AiuzErjTuPuP6EGyjmIEIp-XxJusuB7k_r1E.yFhIcqzq_ISmyEHcb5KMcgPZ7dNbkaC_V79aRPAG_2HgdScSqMi4gqfrWw~9ebb1183c7998dc59a1294972bf94746

Analyst Recommendations on Biodexa Pharmaceuticals Plc

Ladenburg Thalmann Starts Biodexa Pharmaceuticals With Buy Rating, $8 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6421 GBP
Average target price
6.257 GBP
Spread / Average Target
+874.47%
High Price Target
6.257 GBP
Spread / Highest target
+874.47%
Low Price Target
6.257 GBP
Spread / Lowest Target
+874.47%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Biodexa Pharmaceuticals Plc

Ladenburg Thalmann

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BDRX Stock
  4. Consensus Biodexa Pharmaceuticals Plc